180 likes | 616 Views
2. Aetiology and incidence. More common in people between 50 and 70.90% transitional cell carcinomaSquamous cell carcinomaMain cause cigarette smokingCancers of prostate, colon, rectum and female genital organs may metastasize to bladder. 3. Clinical Manifestations. Usually arise at the ba
E N D
1. 1 Cancer of the bladder
2. 2 Aetiology and incidence More common in people between 50 and 70.
90% transitional cell carcinoma
Squamous cell carcinoma
Main cause cigarette smoking
Cancers of prostate, colon, rectum and female genital organs may metastasize to bladder
3. 3 Clinical Manifestations Usually arise at the base; involve ureteral orifices and bladder neck.
Painless haematuria – most common symptom
Infection – common complication
Frequency
Urgency
Dysuria
Back pain may occur with metastasis
4. 4 Assessment and diagnostic findings Cystocopy
Excretory urography
CT scan
USGM
Biopsy
Cytologic examination of the wahings of the bladder.
Newer diagnostic indicators are being studied :
Bladder tumour antigens
Nuclear matrix proteins
Adhesion molecules
Cytoskeletal proteins
Growth factors
Molecular assay
5. 5 Risk Factors for Bladder Cancer Cigarette smoking; risk proportional to number of packets
Environmental carcinogens, dyes, rubber, leather ink or paint
Recurrent or chronic bacterial infection of the urinary tract
Bladder stones
High urinary pH
High cholesterol intake
Pelvic radiation therapy
Cancers arising from the prostate, colon, rectum in males
6. 6 Treatment
Standard therapies for bladder cancer include
Surgery
radiation therapy
Chemotherapy
Immunotherapy
biological therapy. Immune system forms substances in the blood that work against "invaders," such as abnormal cells (that is, cancer cells).Sometimes, the immune system becomes overwhelmed by the very aggressive cancer cells. Biological therapy, or immunotherapy, helps bolster the immune system in its fight against the cancer.Biological therapy is typically given only in stages Ta, T1, and CIS bladder cancers.One widely used immunotherapy or biological therapy in bladder cancer is intravesical BCG treatment. A fluid containing BCG is introduced into the bladder through a thin catheter that has been passed through the urethra.The Mycobacterium in the fluid stimulates the immune system to produce cancer-fighting substances. The solution is held in the bladder for a few hours, then drained. This treatment is repeated every week for six weeks and repeated at various times over several months or even longer in some cases. Researchers are still working to determine the best length of time for these treatments. Over time, the treatments may be required on a less frequent basis.
Immune system forms substances in the blood that work against "invaders," such as abnormal cells (that is, cancer cells).Sometimes, the immune system becomes overwhelmed by the very aggressive cancer cells. Biological therapy, or immunotherapy, helps bolster the immune system in its fight against the cancer.Biological therapy is typically given only in stages Ta, T1, and CIS bladder cancers.One widely used immunotherapy or biological therapy in bladder cancer is intravesical BCG treatment. A fluid containing BCG is introduced into the bladder through a thin catheter that has been passed through the urethra.The Mycobacterium in the fluid stimulates the immune system to produce cancer-fighting substances. The solution is held in the bladder for a few hours, then drained. This treatment is repeated every week for six weeks and repeated at various times over several months or even longer in some cases. Researchers are still working to determine the best length of time for these treatments. Over time, the treatments may be required on a less frequent basis.
7. 7 Medical Management Consider :
The grade of the cancer (the degree of cellular differentiation)
The stage of the tumour growth(the degree of local invasion and the presence or absence of metastasis)
The multicentricity (having many centers) of the tumour
The patient’s age, and physical, mental and emotional status
8. 8 Pharmacologic therapy
Combination of methotrexate, 5-fluorouracil, vinblastine, doxorubicin (adriamycin), cyclophosphamide
Gemcitabine and the taxanes – promising improvement
Topical therapy – instillation into the bladder of thiotepa, doxorubicin,mitomycin, ethoglucid and BCG
9. 9 Surgical Management Transurethral resection or fulguration for simple papillomas
After these procedures which spare the bladder intravesical administration of BCG is the treatment of choice
Simple cystectomy – for invasive or multifocal bladder cancers
Radical cystectomy – which involve near by structures
Transurethral resection of the tumour + radiation + chemotherapy
10. 10